Further Development 8.6: Defining the Role of SKN-1 and PAL-1 in Early Cell Specifications in C. Elegans

Snails, Flowers, and Nematodes: Different Mechanisms for Similar Patterns of Specification

The SKN-1 protein is a maternally expressed transcription factor that controls the fate of the EMS blastomere, the cell that generates the posterior pharynx. After first cleavage, only the posterior blastomere—P1—has the ability to produce pharyngeal cells when isolated. After P1 divides, only EMS is able to generate pharyngeal muscle cells in isolation (Priess and Thomson 1987). Similarly, when the EMS cell divides, only one of its progeny, MS, has the intrinsic ability to generate pharyngeal tissue. These findings suggest that pharyngeal cell fate may be determined autonomously by maternal factors residing in the cytoplasm that are parceled out to these particular cells.

Bowerman and co-workers (1992a, b, 1993) found maternal effect mutants lacking pharyngeal cells and were able to isolate a mutation in the skn-1 (skin excess) gene. Embryos from homozygous skn-1-deficient mothers lack both pharyngeal mesoderm and endoderm derivatives of EMS (Figure 1). Instead of making the normal intestinal and pharyngeal structures, these embryos seem to make extra hypodermal (skin) and body wall tissue where their intestine and pharynx should be. In other words, the EMS blastomere appears to be respecified as C. Only those cells destined to form pharynx or intestine are affected by this mutation. The SKN-1 protein is a transcription factor that initiates the activation of those genes responsible for forming the pharynx and intestine (Blackwell et al. 1994; Maduro et al. 2001).

Another transcription factor, PAL-1, is also required for the differentiation of the P1 lineage. PAL-1 activity is needed for the normal development of the somatic (but not the germline) descendants of the P2 blastomere, where it specifies muscle production. Embryos lacking PAL-1 have no somatic cell types derived from the C and D stem cells (Hunter and Kenyon 1996). PAL-1 is regulated by the MEX-3 protein, an RNA-binding protein that appears to inhibit the translation of pal-1 mRNA. Wherever MEX-3 is expressed, PAL-1 is absent. Thus, in mex-3-deficient mutants, PAL-1 is seen in every blastomere. SKN-1 also inhibits PAL-1 (thereby preventing it from becoming active in the EMS cell). But what keeps pal-1 from functioning in the prospective germ cells and turning them into muscles? In the germ line, PAL-1 synthesis is prevented by the PUF-8 protein, which binds to the 3′ UTR of pal-1 mRNA and blocks its translation (Mainpal et al. 2011).

A third transcription factor, PIE-1, is necessary for germline cell fate. PIE-1 is placed into the P blastomeres through the action of the PAR-1 protein (Figure 2), and it appears to inhibit both SKN-1 and PAL-1 function in the P2 and subsequent germline cells (Hunter and Kenyon 1996). Mutations of the maternal pie-1 gene result in germline blastomeres adopting somatic fates, with the P2 cell behaving similarly to a wild-type EMS blastomere. The localization and the genetic properties of PIE-1 suggest that it represses the establishment of somatic cell fate and preserves the totipotency of the germ cell lineage (Mello et al. 1996; Seydoux et al. 1996).

Figure 1 Deficiencies of intestine and pharynx in skn-1 mutants of C. elegans. Embryos derived from wild-type animals (A,C) and from animals homozygous for mutant skn-1 (B,D) were tested for the presence of pharyngeal muscles (A,B) and gut-specific granules (C,D). A pharyngeal muscle-specific antibody labels the pharynx musculature of those embryos derived from wild-type (A) but does not bind to any structure in the embryos from skn-1 mutants (B). Similarly, the gut granules characteristic of embryonic intestines (C) are absent from embryos derived from the skn-1 mutants (D).
Figure 2 Segregation of PIE-1 determinant into the P1 blastomere at the 2-cell stage. The sperm centrosome inhibits the presence of the PAR-3/PAR-6 complex in the posterior of the egg. This allows the function of PAR-2 and PAR-1, which inhibit the MEX-5 and MEX-6 proteins that would degrade PIE-1. So while PIE-1 is degraded in the resulting anterior AB cell, it is preserved in the posterior P1 cell. (After P. Gönczy and L. S. Rose. October 15, 2005. WormBook, ed. The C. elegans Research Community, WormBook, doi/10.1895/wormbook.1.30.1, http://www.wormbook.org/CC BY 2.5.)


Blackwell, T. K., B. Bowerman, J. R. Priess and H. Weintraub. 1994. Formation of a monomeric DNA binding domain by SKN bZIP and homeodomain elements. Science 266: 621–628.
PubMed Link

Hunter, C. P. and C. Kenyon. 1996. Spatial and temporal controls target pal-1blastomere-specification activity to a single blastomere in C. elegans embryos. Cell 87: 217–226.
PubMed Link

Maduro, M. F., M. D. Meneghini, B. Bowerman, G. Broitman-Maduro and J. H. Rothman. 2001. Restriction of mesendoderm to a single blastomere by the combined action of SKN-1 and a GSK-3b homolog is mediated by MED-1 and -2 in C. elegans. Mol. Cell 7: 475–485.
PubMed Link

Mainpal, R., A. Priti and K. Subramaniam. 2011. PUF-8 suppresses the somatic transcription factor PAL-1 expression in C. elegansgermline stem cells. Dev. Biol. 360: 195–207.
PubMed Link

Mello, C. C., C. Schubert, B. Draper, W. Zhang, R. Lobel and J. R. Priess. 1996. The PIE-1 protein and germline specification in C. elegans embryos. Nature 382: 710–712.
PubMed Link

Priess, R. A. and J. N. Thomson. 1987. Cellular interactions in early C. elegans embryos. Cell 48: 241–250.
PubMed Link

Seydoux, G., C. C. Mello, J. Pettitt, W. B. Wood, J. R. Priess and A. Fire. 1996. Repression of gene expression in the embryonic germ lineage of C. elegansNature 382: 713–716.
PubMed Link

All the material on this website is protected by copyright. It may not be reproduced in any form without permission from the copyright holder.